The purpose of this study is to determine of once identified to the subjects infected with human immunodeficiency virus (positive VIH), to diagnose latent Tuberculosis, and to treat her with isoniazid for six months, measuring the production of Interferon range pre and posttreatment, to evaluate this way the result of the treatment on the immune response
A descriptive analysis of the data will be made. Means and standard deviations for continuous data frequencies for categorical data will be performed. Wilcoxon test Mann-Whitney U test Chi square will be used for frequency analysis of responders Data Analysis and Statistical Software(STATA).
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
PREVENTION
Masking
NONE
Enrollment
100
Isoniazid, 10 mg/Kg/day, no more than 300 mg/day, for six months
Instituto Nacional de Salud Publica
México, Cuernavaca Morelos, Mexico
Clínica Especializada CONDESA
Mexico City, D.F, Mexico
Production of interferon gamma, in response to treatment of latent infection
Time frame: Before and after treatment intake
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.